Content deleted Content added
Fgnievinski (talk | contribs) |
Fgnievinski (talk | contribs) |
||
Line 10:
To emulate the human mind's cognitive powers, Definiens used patented [[image segmentation]] and classification processes, and developed a method to render knowledge in a [[semantic network]]. CNT examines pixels not in isolation, but in context. It builds up a picture iteratively, recognizing groups of pixels as objects. It uses the color, shape, texture and size of objects as well as their context and relationships to draw conclusions and inferences, similar to a human analyst.
== Company ==
It was first available with the launch of the ''eCognition'' software in May 2000.▼
In 1994 Professor Gerd Binnig founded ''Definiens''.
In June 2010, [[Trimble Navigation Ltd]] (NASDAQ: TRMB) acquired Definiens business asset in [[earth sciences]] markets,<ref>Trimble / Definiens Joint Press Release: "Trimble Acquires Definiens’ Earth Sciences Business to Expand its GeoSpatial Portfolio". June 11, 2010. http://www.ecognition.com/sites/default/files/Trimble%20eCognition.pdf</ref>, including eCognition software, and also licensed Definiens' patented CNT.<ref>[http://www.trimble.com/Corporate/About_History.aspx]</ref>
In 2014, Definiens was acquired by [[MedImmune]], the global biologics research and development arm of AstraZeneca, for an initial consideration of $150 million.<ref>[https://www.astrazeneca.com/media-centre/press-releases/2014/medimmune-definiens-aquisition-tissue-phenomics-26112014.html]</ref>
== Software ==
| |||